3-171603117-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_002662.5(PLD1):c.3186G>A(p.Gly1062=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,613,854 control chromosomes in the GnomAD database, including 908 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.047 ( 414 hom., cov: 32)
Exomes 𝑓: 0.015 ( 494 hom. )
Consequence
PLD1
NM_002662.5 synonymous
NM_002662.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0930
Genes affected
PLD1 (HGNC:9067): (phospholipase D1) This gene encodes a phosphatidylcholine-specific phospholipase which catalyzes the hydrolysis of phosphatidylcholine in order to yield phosphatidic acid and choline. The enzyme may play a role in signal transduction and subcellular trafficking. Alternative splicing results in multiple transcript variants with both catalytic and regulatory properties. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 3-171603117-C-T is Benign according to our data. Variant chr3-171603117-C-T is described in ClinVar as [Benign]. Clinvar id is 1266999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.093 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.137 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLD1 | NM_002662.5 | c.3186G>A | p.Gly1062= | synonymous_variant | 27/27 | ENST00000351298.9 | NP_002653.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLD1 | ENST00000351298.9 | c.3186G>A | p.Gly1062= | synonymous_variant | 27/27 | 1 | NM_002662.5 | ENSP00000342793 | A1 | |
PLD1 | ENST00000356327.9 | c.3072G>A | p.Gly1024= | synonymous_variant | 26/26 | 1 | ENSP00000348681 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0471 AC: 7160AN: 152070Hom.: 413 Cov.: 32
GnomAD3 genomes
AF:
AC:
7160
AN:
152070
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0177 AC: 4458AN: 251216Hom.: 170 AF XY: 0.0151 AC XY: 2051AN XY: 135774
GnomAD3 exomes
AF:
AC:
4458
AN:
251216
Hom.:
AF XY:
AC XY:
2051
AN XY:
135774
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0152 AC: 22216AN: 1461666Hom.: 494 Cov.: 31 AF XY: 0.0143 AC XY: 10415AN XY: 727134
GnomAD4 exome
AF:
AC:
22216
AN:
1461666
Hom.:
Cov.:
31
AF XY:
AC XY:
10415
AN XY:
727134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0472 AC: 7176AN: 152188Hom.: 414 Cov.: 32 AF XY: 0.0452 AC XY: 3361AN XY: 74424
GnomAD4 genome
AF:
AC:
7176
AN:
152188
Hom.:
Cov.:
32
AF XY:
AC XY:
3361
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
47
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at